API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
79
PharmaCompass offers a list of Ethinyl Estradiol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ethinyl Estradiol manufacturer or Ethinyl Estradiol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ethinyl Estradiol manufacturer or Ethinyl Estradiol supplier.
PharmaCompass also assists you with knowing the Ethinyl Estradiol API Price utilized in the formulation of products. Ethinyl Estradiol API Price is not always fixed or binding as the Ethinyl Estradiol Price is obtained through a variety of data sources. The Ethinyl Estradiol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol, including repackagers and relabelers. The FDA regulates 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol supplier is an individual or a company that provides 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol active pharmaceutical ingredient (API) or 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol finished formulations upon request. The 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol suppliers may include 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol API manufacturers, exporters, distributors and traders.
click here to find a list of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol DMF (Drug Master File) is a document detailing the whole manufacturing process of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol active pharmaceutical ingredient (API) in detail. Different forms of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol DMFs exist exist since differing nations have different regulations, such as 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol DMF submitted to regulatory agencies in the US is known as a USDMF. 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol USDMF includes data on 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol Drug Master File in Japan (17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol JDMF) empowers 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol JDMF during the approval evaluation for pharmaceutical products. At the time of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol suppliers with JDMF on PharmaCompass.
A 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol CEP of the European Pharmacopoeia monograph is often referred to as a 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol Certificate of Suitability (COS). The purpose of a 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol to their clients by showing that a 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol CEP has been issued for it. The manufacturer submits a 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol CEP (COS) as part of the market authorization procedure, and it takes on the role of a 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol CEP holder for the record. Additionally, the data presented in the 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol DMF.
A 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol suppliers with CEP (COS) on PharmaCompass.
A 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol written confirmation (17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol WC) is an official document issued by a regulatory agency to a 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol manufacturer, verifying that the manufacturing facility of a 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol APIs or 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol finished pharmaceutical products to another nation, regulatory agencies frequently require a 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol WC (written confirmation) as part of the regulatory process.
click here to find a list of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol suppliers with NDC on PharmaCompass.
17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol GMP manufacturer or 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol GMP API supplier for your needs.
A 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol CoA (Certificate of Analysis) is a formal document that attests to 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol's compliance with 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol specifications and serves as a tool for batch-level quality control.
17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol CoA mostly includes findings from lab analyses of a specific batch. For each 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol may be tested according to a variety of international standards, such as European Pharmacopoeia (17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol EP), 17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol USP).